ES
IBB icon

Eagle Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Eagle Strategies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.22M Buy
22,192
+1,055
+5% +$181K 0.42% 53
2026
Q1 		$3.57M Buy
21,137
+8,851
+72% +$1.51M 0.43% 58
2025
Q4 		$2.07M Sell
12,286
-43
-0.3% -$6.98K 0.26% 77
2025
Q3 		$1.78M Buy
12,329
+90
+0.7% +$12.3K 0.24% 90
2025
Q2 		$1.55M Sell
12,239
-561
-4% -$68.9K 0.24% 87
2025
Q1 		$1.64M Buy
12,800
+1,181
+10% +$160K 0.28% 71
2024
Q4 		$1.54M Buy
11,619
+354
+3% +$49.8K 0.27% 73
2024
Q3 		$1.64M Sell
11,265
-409
-4% -$59.2K 0.3% 70
2024
Q2 		$1.6M Buy
11,674
+9,883
+552% +$1.32M 0.31% 71
2024
Q1 		$246K Sell
1,791
-9,297
-84% -$1.27M 0.05% 236
2023
Q4 		$1.51M Sell
11,088
-75
-0.7% -$9.15K 0.32% 67
2023
Q3 		$1.37M Buy
11,163
+646
+6% +$82.2K 0.34% 66
2023
Q2 		$1.34M Buy
10,517
+143
+1% +$18.6K 0.32% 68
2023
Q1 		$1.34M Buy
10,374
+211
+2% +$27.6K 0.33% 62
2022
Q4 		$1.33M Buy
10,163
+515
+5% +$66.6K 0.4% 59
2022
Q3 		$1.13M Buy
9,648
+1,289
+15% +$160K 0.59% 41
2022
Q2 		$983K Buy
8,359
+4,101
+96% +$487K 0.36% 60
2022
Q1 		$555K Sell
4,258
-7,488
-64% -$975K 0.22% 79
2021
Q4 		$1.79M Buy
+11,746
New +$1.82M 0.7% 39

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Eagle Strategies's IBB Position: Q2 2026 in Review

Eagle Strategies increased its iShares Biotechnology ETF (IBB) stake by 5% in Q2 2026, buying an estimated $181K and bringing the position to 22,192 shares worth $4.22M. The position accounts for 0.42% of the portfolio, ranked #53.

Eagle Strategies first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 451 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Eagle Strategies held 22,192 shares of iShares Biotechnology ETF worth $4.22M as of Q2 2026.
  • Eagle Strategies bought 1,055 iShares Biotechnology ETF shares in Q2 2026, an estimated $181K.
  • iShares Biotechnology ETF made up 0.42% of Eagle Strategies's portfolio in Q2 2026, its #53 holding.
  • Eagle Strategies first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 451 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Eagle Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.